Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy using cardiovascular magnetic resonance

[1]  Lidia Chojnowska,et al.  Comparison of different quantification methods of late gadolinium enhancement in patients with hypertrophic cardiomyopathy. , 2010, European journal of radiology.

[2]  A. Tajik,et al.  Characteristics and Clinical Significance of Late Gadolinium Enhancement by Contrast-Enhanced Magnetic Resonance Imaging in Patients With Hypertrophic Cardiomyopathy , 2010, Circulation. Heart failure.

[3]  N. Smedira,et al.  Cardiac magnetic resonance detection of myocardial scarring in hypertrophic cardiomyopathy: correlation with histopathology and prevalence of ventricular tachycardia. , 2009, Journal of the American College of Cardiology.

[4]  Warren J Manning,et al.  Clinical Profile and Significance of Delayed Enhancement in Hypertrophic Cardiomyopathy , 2008, Circulation. Heart failure.

[5]  E. Nagel,et al.  Standardized cardiovascular magnetic resonance imaging (CMR) protocols, society for cardiovascular magnetic resonance: board of trustees task force on standardized protocols , 2008, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[6]  W. Manning,et al.  Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance. , 2008, Journal of the American College of Cardiology.

[7]  Mario J. Garcia,et al.  Association of myocardial fibrosis, electrocardiography and ventricular tachyarrhythmia in hypertrophic cardiomyopathy: a delayed contrast enhanced MRI study , 2008, The International Journal of Cardiovascular Imaging.

[8]  J. Rumberger.  Assessment of Cardiac Function , 2008 .

[9]  Katherine C. Wu,et al.  Infarct Tissue Heterogeneity by Magnetic Resonance Imaging Identifies Enhanced Cardiac Arrhythmia Susceptibility in Patients With Left Ventricular Dysfunction , 2007, Circulation.

[10]  Vivek Y. Reddy,et al.  Remote Magnetic Navigation to Guide Endocardial and Epicardial Catheter Mapping of Scar-Related Ventricular Tachycardia , 2007, Circulation.

[11]  Dudley J Pennell,et al.  Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. , 2006, Journal of the American College of Cardiology.

[12]  W. Manning,et al.  Prevalence, Clinical Profile, and Significance of Left Ventricular Remodeling in the End-Stage Phase of Hypertrophic Cardiomyopathy , 2006, Circulation.

[13]  D. Pennell,et al.  Normalized left ventricular systolic and diastolic function by steady state free precession cardiovascular magnetic resonance. , 2006, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[14]  D. Pennell,et al.  Myocardial late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy caused by mutations in troponin I , 2005, Heart.

[15]  Dudley J Pennell,et al.  The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy. , 2004, Journal of the American College of Cardiology.

[16]  Dan W Rettmann,et al.  Accurate and Objective Infarct Sizing by Contrast-enhanced Magnetic Resonance Imaging in a Canine Myocardial Infarction Model , 2022 .

[17]  D. Pennell,et al.  Cardiovascular magnetic resonance , 2001, Heart.

[18]  Barry J Maron,et al.  American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice G , 2003, Journal of the American College of Cardiology.

[19]  M. Chiariello,et al.  Myocardial Collagen Turnover in Hypertrophic Cardiomyopathy , 2003, Circulation.

[20]  D. Pennell,et al.  Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. , 2003, Journal of the American College of Cardiology.

[21]  Heiko Mahrholdt,et al.  Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy. , 2002, Journal of the American College of Cardiology.

[22]  D. Pennell,et al.  Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy. , 2002, The American journal of cardiology.

[23]  R. Devereux,et al.  Impact of diastolic doppler indices on exercise capacity in hypertensive patients with electrocardiographic left ventricular hypertrophy (a LIFE substudy) , 2002, Journal of hypertension.

[24]  B. Maron.  Hypertrophic cardiomyopathy: a systematic review. , 2002, JAMA.

[25]  Ali Massumi,et al.  Magnetic resonance imaging of myocardial fibrosis in hypertrophic cardiomyopathy. , 2002, Texas Heart Institute journal.

[26]  W J McKenna,et al.  Relation between myocyte disarray and outcome in hypertrophic cardiomyopathy. , 2001, The American journal of cardiology.

[27]  O. Simonetti,et al.  An improved MR imaging technique for the visualization of myocardial infarction. , 2001, Radiology.

[28]  O. Simonetti,et al.  The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. , 2000, The New England journal of medicine.

[29]  W. Roberts,et al.  Morphology and significance of the left ventricular collagen network in young patients with hypertrophic cardiomyopathy and sudden cardiac death. , 2000, Journal of the American College of Cardiology.

[30]  F O Mueller,et al.  Sudden death in young competitive athletes. Clinical, demographic, and pathological profiles. , 1996, JAMA.

[31]  Prevalence of Hypertrophic Cardiomyopathy in a General Population of Young Adults: Echocardiographic Analysis of 4111 Subjects in the Cardia Study , 1996 .

[32]  J. Gardin,et al.  Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults. , 1995, Circulation.

[33]  D. Collet.  Modelling Survival Data in Medical Research , 2004 .

[34]  M. Burch,et al.  Hypertrophic cardiomyopathy. , 1994, Archives of disease in childhood.

[35]  Capelle,et al.  Slow conduction in the infarcted human heart. 'Zigzag' course of activation. , 1993, Circulation.

[36]  D Revel,et al.  Differentiation of reversible and irreversible myocardial injury by MR imaging with and without gadolinium-DTPA. , 1986, Radiology.

[37]  J. Ross,et al.  Assessment of Cardiac Function , 1969 .